Skip to Primary Navigation

Skip to main content

Florida lab settles FCA case for $9.8m after self-disclosure of violations

A photo of just the hands of two men in black suits and white shirts shaking in agreement.
Photo: Sean Gallup/Getty Images

Kevin Kinsella

2 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

By voluntarily self-disclosing the violations and cooperating with the DOJ, the testing laboratory avoided open-ended exposure, a corporate integrity agreement, and exclusion from federal programs.

The US Department of Justice (DOJ) has announced the resolution of civil allegations against an oncology testing laboratory in Florida for violating the False Claims Act (FCA). It had been alleged that the lab provided consulting services at below fair market value to certain healthcare providers that referred beneficiaries to

, , , , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience